More Medical Developments International Limited news
Medical Developments International LimitedASX: MVP

S&P DJ Indices Announces March Quarterly Rebalance

Nov 6, 2016 at 7:29 PM EST · Issued by Medical Developments International Limited

Filed with ASX · Nov 6, 2016 at 7:29 PM EST · 10 pages · English

On 6ix: 6ix.com/news/sandp-dj-indices-announces-march-quarterly-rebalance-164

Watch Medical Developments International's latest callMedical Developments International (ASX:MVP) Q4 2026 Earnings Call · Replay · Aug 19↗

Medical Developments International Limited on 6ix

Earlier from Medical Developments International

  • MVP signs major deal with CSIROOct 27, 2016
  • MVP signs Licensing Agreement for Penthrox in CandaSep 12, 2016
  • Penthrox receives regulatory approval in the UAESep 8, 2016
  • Licensing deal for KoreaSep 5, 2016
  • European Penthrox UpdateAug 11, 2016

Later from Medical Developments International

  • S&P DJ Indices Announces March Quarterly ReviewNov 7, 2016
  • POST TRUMP - Business as usual, MVP signs a Respiratory dealNov 13, 2016
  • Penthrox submitted for approval in 22 European CountriesNov 29, 2016
  • Penthrox approved for sale in TaiwanDec 7, 2016
  • Penthrox European UpdateFeb 6, 2017
All Medical Developments International news releases↗

Follow Medical Developments International into a list and get an email when it puts out news.

Follow Medical Developments International
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer